Advanced Malignant Tumor

Oncology
8
Pipeline Programs
2
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
6
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Qilu Pharmaceutical
Qilu PharmaceuticalChina - Jinan
4 programs
3
1
QL1604Phase 21 trial
QL1706Phase 11 trial
QLS1304 tabletPhase 11 trial
QLS31901Phase 11 trial
Active Trials
NCT04296994UnknownEst. Dec 2023
NCT06823609RecruitingEst. Dec 2027
NCT04954456UnknownEst. Dec 2022
+1 more trials
CT
4 programs
3
1
TQ-B3101Phase 21 trial
TQB2868 InjectionPhase 11 trial
TQB3909 TabletsPhase 11 trial
TQB3915 tabletsPhase 11 trial
Active Trials
NCT05198505UnknownEst. Jun 2024
NCT04975204UnknownEst. Aug 2024
NCT05416359UnknownEst. Jun 2024
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Chia Tai TianQing Pharmaceutical GroupTQ-B3101
Qilu PharmaceuticalQL1604
Qilu PharmaceuticalQLS1304 tablet
Chia Tai TianQing Pharmaceutical GroupTQB3915 tablets
Chia Tai TianQing Pharmaceutical GroupTQB2868 Injection
Chia Tai TianQing Pharmaceutical GroupTQB3909 Tablets
Qilu PharmaceuticalQLS31901
Qilu PharmaceuticalQL1706

Clinical Trials (8)

NCT04412564Chia Tai TianQing Pharmaceutical GroupTQ-B3101

A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

Start: Aug 2020Est. completion: Sep 2021
Phase 2Unknown
NCT04326829Qilu PharmaceuticalQL1604

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Start: Jul 2020Est. completion: Jul 2023
Phase 2Unknown
NCT06823609Qilu PharmaceuticalQLS1304 tablet

Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors

Start: Mar 2025Est. completion: Dec 2027
Phase 1Recruiting
NCT05416359Chia Tai TianQing Pharmaceutical GroupTQB3915 tablets

Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors

Start: Jun 2022Est. completion: Jun 2024
Phase 1Unknown
NCT05198505Chia Tai TianQing Pharmaceutical GroupTQB2868 Injection

Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors

Start: Apr 2022Est. completion: Jun 2024
Phase 1Unknown
NCT04975204Chia Tai TianQing Pharmaceutical GroupTQB3909 Tablets

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Start: Feb 2022Est. completion: Aug 2024
Phase 1Unknown
NCT04954456Qilu PharmaceuticalQLS31901

A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies

Start: Jun 2021Est. completion: Dec 2022
Phase 1Unknown
NCT04296994Qilu PharmaceuticalQL1706

A Study of QL1706 in Subjects With Advanced Malignant Tumor

Start: Mar 2020Est. completion: Dec 2023
Phase 1Unknown

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
4h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
4h ago

Office Administrator

SystImmune
4h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
4h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
4h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
4h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space

Related Indications

Breast Cancer(577)Prostate Cancer(385)Non-small Cell Lung Cancer(378)Multiple Myeloma(359)Cancer(249)Advanced Solid Tumors(226)Acute Myeloid Leukemia(209)Neoplasms(199)Colorectal Cancer(171)Melanoma(170)